MARKET

ELDN

ELDN

Eledon Pharmaceuticals Inc
NASDAQ
2.925
+0.145
+5.22%
Opening 14:53 03/09 EDT
OPEN
2.890
PREV CLOSE
2.780
HIGH
3.100
LOW
2.840
VOLUME
1.85M
TURNOVER
--
52 WEEK HIGH
4.600
52 WEEK LOW
1.350
MARKET CAP
219.48M
P/E (TTM)
-29.4266
1D
5D
1M
3M
1Y
5Y
1D
NewcelX announces research agreement with Eledon Pharmaceuticals
TipRanks · 7h ago
Newcelx Announces Collaborative Research Agreement With Eledon Pharmaceuticals To Advance The NCEL-101 Program For Type 1 Diabetes
Benzinga · 7h ago
Weekly Report: what happened at ELDN last week (0302-0306)?
Weekly Report · 8h ago
Eledon Pharmaceuticals to Join Leerink Partners 2026 Global Healthcare Conference Fireside Chat
Reuters · 4d ago
Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference
Barchart · 5d ago
Weekly Report: what happened at ELDN last week (0223-0227)?
Weekly Report · 03/02 10:26
Weekly Report: what happened at ELDN last week (0216-0220)?
Weekly Report · 02/23 10:26
Weekly Report: what happened at ELDN last week (0209-0213)?
Weekly Report · 02/16 10:26
More
About ELDN
Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing immune-modulating therapies for the management and treatment of life-threatening conditions. The Company’s lead investigational product is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for CD40 Ligand, a well-validated biological target within the costimulatory CD40/CD40L cellular pathway. The central role of CD40L signaling in both adaptive and innate immune cell activation and function positions it as an attractive target for non-lymphocyte depleting, immunomodulatory therapeutic intervention. Tegoprubart is engineered to potentially both improve safety and provides pharmacokinetic, pharmacodynamic, and dosing advantages. CD40L is primarily expressed on activated CD4+ T cells, platelets, and endothelial cells while the CD40 receptor is constitutively expressed on antigen-presenting cells, such as macrophages and dendritic cells, as well as B cells.

Webull offers Eledon Pharmaceuticals Inc stock information, including NASDAQ: ELDN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELDN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ELDN stock methods without spending real money on the virtual paper trading platform.